Akoya Biosciences, Inc. (AKYA)
NASDAQ: AKYA · Real-Time Price · USD
1.350
-0.040 (-2.88%)
At close: Apr 1, 2025, 4:00 PM
1.330
-0.020 (-1.48%)
After-hours: Apr 1, 2025, 7:00 PM EDT
Akoya Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Cash & Equivalents | 11.78 | 83.13 | 74.23 | 113.08 | 17.01 | Upgrade
|
Short-Term Investments | 23.26 | - | 6.99 | - | - | Upgrade
|
Cash & Short-Term Investments | 35.04 | 83.13 | 81.22 | 113.08 | 17.01 | Upgrade
|
Cash Growth | -57.85% | 2.35% | -28.18% | 564.94% | -21.48% | Upgrade
|
Accounts Receivable | 13.78 | 16.99 | 9.73 | 9.44 | 6.47 | Upgrade
|
Other Receivables | - | - | - | 5.09 | - | Upgrade
|
Receivables | 13.78 | 16.99 | 9.73 | 14.54 | 6.47 | Upgrade
|
Inventory | 24.32 | 17.88 | 14.49 | 9.01 | 4.26 | Upgrade
|
Prepaid Expenses | 3.26 | 3.79 | 6.76 | 4.18 | 0.96 | Upgrade
|
Other Current Assets | 0.33 | - | - | - | - | Upgrade
|
Total Current Assets | 76.73 | 121.79 | 112.2 | 140.81 | 28.7 | Upgrade
|
Property, Plant & Equipment | 12.98 | 20.66 | 22.45 | 7.49 | 5.53 | Upgrade
|
Goodwill | 18.26 | 18.26 | 18.26 | 18.26 | 18.26 | Upgrade
|
Other Intangible Assets | 14.56 | 17.41 | 20.05 | 21.15 | 22.71 | Upgrade
|
Long-Term Deferred Tax Assets | 0.13 | 0.04 | 0.04 | - | - | Upgrade
|
Long-Term Deferred Charges | - | 0.33 | 0.33 | - | 0.27 | Upgrade
|
Other Long-Term Assets | 2.34 | 1.88 | 2.71 | 3.19 | 2.19 | Upgrade
|
Total Assets | 125.01 | 180.37 | 176.03 | 190.91 | 77.66 | Upgrade
|
Accounts Payable | 8.76 | 11.78 | 10.63 | 9.44 | 5.07 | Upgrade
|
Accrued Expenses | 8.5 | 10.43 | 11.16 | 12.28 | 5.43 | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | - | 1.03 | Upgrade
|
Current Portion of Leases | 3.28 | 3.45 | 3.63 | 0.27 | 0.2 | Upgrade
|
Current Unearned Revenue | 6.55 | 6.69 | 6.28 | 4.48 | 3.84 | Upgrade
|
Other Current Liabilities | 2.35 | 3.01 | 5.36 | 1.21 | 1.59 | Upgrade
|
Total Current Liabilities | 29.44 | 35.35 | 37.06 | 27.68 | 17.16 | Upgrade
|
Long-Term Debt | 76.18 | 75.25 | 63.28 | 32.47 | 33.49 | Upgrade
|
Long-Term Leases | 4.68 | 7 | 8.88 | 0.2 | 0.28 | Upgrade
|
Long-Term Unearned Revenue | 3.06 | 3.19 | 2.11 | 1.33 | 1.01 | Upgrade
|
Long-Term Deferred Tax Liabilities | 0.13 | 0.04 | 0.09 | 0.03 | 0.17 | Upgrade
|
Other Long-Term Liabilities | 3.91 | 5.77 | 6.04 | 7.85 | 7.47 | Upgrade
|
Total Liabilities | 117.41 | 126.6 | 117.45 | 69.56 | 59.58 | Upgrade
|
Common Stock | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Additional Paid-In Capital | 293.02 | 283.84 | 225.33 | 217.46 | - | Upgrade
|
Retained Earnings | -285.44 | -230.07 | -166.75 | -96.11 | -52.28 | Upgrade
|
Comprehensive Income & Other | 0.01 | - | -0.01 | - | - | Upgrade
|
Total Common Equity | 7.6 | 53.77 | 58.58 | 121.35 | -52.28 | Upgrade
|
Shareholders' Equity | 7.6 | 53.77 | 58.58 | 121.35 | 18.08 | Upgrade
|
Total Liabilities & Equity | 125.01 | 180.37 | 176.03 | 190.91 | 77.66 | Upgrade
|
Total Debt | 84.15 | 85.71 | 75.78 | 32.94 | 34.99 | Upgrade
|
Net Cash (Debt) | -49.11 | -2.58 | 5.43 | 80.14 | -17.99 | Upgrade
|
Net Cash Growth | - | - | -93.22% | - | - | Upgrade
|
Net Cash Per Share | -0.99 | -0.06 | 0.14 | 2.98 | -7.59 | Upgrade
|
Filing Date Shares Outstanding | 49.82 | 49.14 | 38.34 | 37.48 | 2.56 | Upgrade
|
Total Common Shares Outstanding | 49.57 | 49.12 | 38.29 | 37.42 | 2.56 | Upgrade
|
Working Capital | 47.29 | 86.45 | 75.14 | 113.13 | 11.53 | Upgrade
|
Book Value Per Share | 0.15 | 1.09 | 1.53 | 3.24 | -20.39 | Upgrade
|
Tangible Book Value | -25.23 | 18.1 | 20.27 | 81.94 | -93.26 | Upgrade
|
Tangible Book Value Per Share | -0.51 | 0.37 | 0.53 | 2.19 | -36.37 | Upgrade
|
Machinery | 13.31 | 14.52 | 12.52 | 9.98 | 6.53 | Upgrade
|
Leasehold Improvements | 5.25 | 5.88 | 3.98 | 1.57 | 1.26 | Upgrade
|
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.